Fresenius Kabi Issues Critical Software Update for Ivenix Infusion Pumps
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
The company advises taking any dropped or severely jarred modules out of service and sending them to biomedical engineering for inspection before reuse.
The alert links purge retainer failures to potential pump stops and loss of hemodynamic support; the manufacturer is planning a service update.
FDA identifies Class I recall as most serious type due to software anomalies that may cause unexpected shutdowns and interface freezing.
A software flaw that may cause the Plum Duo Infusion System to become unresponsive has prompted a device correction, which the FDA has identified as its most serious recall type.
Read MoreThe FDA has issued a Class I recall designation for the correction, which addresses a fault that can cause ventilation to stop unexpectedly.
Read MoreBoston Scientificās Endotak Reliance leads with ePTFE-coated coils may reduce shock efficacy due to coil calcification.
Read MoreUpdated guidance addresses ventilator inoperative alarm failures that may lead to therapy loss, with 13 injuries and eight deaths reported.
Read MoreThe FDA issued an early alert under its recall communications pilot citing 79 injuries and two deaths linked to Baxterās Novum IQ infusion pump.
Read MoreThe voluntary recall involves pump modules that may have been repaired with FR-110 bezels, which the company says can weaken over time and compromise safe infusion delivery.
Read More
The Class I recall involves devices with incorrectly assembled B/V filters.